Suzetrigine selectively inhibits the NaV1.8 pain-signaling pathway in the peripheral nervous system and provides effective relief of acute pain without the risk of addiction.
Medscape Medical News
FDA OKs First-In-Class Nonopioid Pain Med Suzetrigine
